By now, there are about 300 medicinal plants successfully used in medical practice. Moreover, recent years showed a steady tendency for extending this class.Obtaining phytopreparations always involves extraction of the biologically active substances, followed by their separation and purification using various technological methods. One of the main negative factors, introducing instability in the manufacture of phytopreparations, is an irregular character of the supply of raw materials for their production. The reasons include, in particular, a sharp decrease in the natural stock of both wild-growing and cultivated medicinal plants.In connection with this, both the search for new medicinal plants and work on creation of a reliable stock of pharmacopoeial plants are of considerable practical value. Besides the traditional work on large-scale cultivation of medicinal plants, a highly promising direction is the biotechnological production of raw plant materials and related preparations.Biotechnology, which means carrying out technological processes with the aid of biological systems, has been rapidly developing in the past years and is recognized as a priority direction in the future scientific progress [ 1 -8].An important field of biotechnology is the growth of plant cells (or medicinal plant tissue cultures), in which the main difficulties are related to development of the necessary commercial equipment. This field is most extensively developed in Japan, where large-scale cultivation of plant cells was successfully realized many years ago (a 20-m 3 biomass reported in 1976) [1].From the standpoint of the commercial growth of cultures, the most efficient technology is that based on bulk cultivation (suspension cell culture). This method reduces the process time and minimizes manual operations as compared